CSIMarket Company Name, Ticker, Suppliers, else..
 
Heron Therapeutics Inc   (NASDAQ: HRTX)
 

Heron Therapeutics Inc's Suppliers Performance

HRTX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
HRTX Costs vs Sales of Suppliers Growth Heron Therapeutics Inc recorded an increase in cost of sales by 28.58 % year on year, sequentially cost of sales grew by 15.72 % in Q2.

• More on HRTX Suppliers



Heron Therapeutics Inc recorded increase in cost of sales by 28.58 % year on year, sequentially cost of sales grew by 15.72 % in Q2.

• More on HRTX Suppliers




Heron Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers and processors to produce active pharmaceutical ingredients, excipients, and finished products in compliance with FDA cGMP and other regulations. Confidentiality agreements are maintained with manufacturers to protect proprietary rights related to the company's products and Biochronomer Technology. Certain critical materials and components are sourced from single suppliers, and supply interruptions could delay or increase commercialization or development costs. Some specialized materials may be newly manufactured or used in non-traditional ways, making reliable and consistent supply sources essential. Obtaining materials on commercially reasonable terms can be challenging, particularly for small quantities or materials not commonly used in pharmaceuticals.

Heron Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers and processors to produce active pharmaceutical ingredients, excipients, and finished products in compliance with FDA cGMP and other regulations. Confidentiality agreements are maintained with manufacturers to protect proprietary rights related to the company's products and Biochronomer Technology. Certain critical materials and components are sourced from single suppliers, and supply interruptions could delay or increase commercialization or development costs. Some specialized materials may be newly manufactured or used in non-traditional ways, making reliable and consistent supply sources essential. Obtaining materials on commercially reasonable terms can be challenging, particularly for small quantities or materials not commonly used in pharmaceuticals.







HRTX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Heron Therapeutics Inc 55.39 151.51 -34.05 128
SUBTOTAL 0.00 0.00 0.00 -


Sources: Heron Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Heron Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.